Late-stage trial planned for Crohn’s disease drug candidate from Celgene

Posted: May 29th, 2015  |  Company/topic: Celgene
A midstage clinical trial of Celgene's GED-0301, or mongersen, found that a 160-milligram dose was associated with remission  -More- …

Celgene’s next-gen psoriasis drug dissed by German cost watchdog

Posted: May 22nd, 2015  |  Company/topic: Celgene
Celgene's Otezla has hit a snag with the notoriously difficult German cost watchdog IQWiG, which said it just doesn't see the added benefit over treatments already on the market.

Cypher Genomics Collaborates with Celgene Corporation to Identify Novel … – PR Newswire (press release)

Posted: May 20th, 2015  |  Company/topic: Celgene
Xconomy…

Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

Posted: May 20th, 2015  |  Company/topic: Celgene
Bruce V. Bigelow Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey’s Celgene (NASDAQ: CELG) identify k…